GL1X · GenesisL1 explorer

Research workbench

Crystal structure of TM0159 with bound imp

Analyse Crystal structure of TM0159 with bound imp in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3S86
Type
protein
Length
756 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nucleoside-triphosphatase
EC
3.6.1.15
UniProt
Q9WY06
Ligands
IMP, SO4
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DNucleoside-triphosphatase (EC 3.6.1.15)protein18934% helix, 26% strandQ9WY06

Ligands and binding sites

  • IMP · Inosinic acid · ligand · 4 copies · chains A, B, C, D
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111360.810.8290empty
211420.760.79122IMP, SO4
31570.630.8631IMP, SO4
41610.620.8430IMP, SO4
5750.360.7615empty

Interfaces

4 interfaces between chains.

  • B–C · 871 Ų buried · 12 hydrogen bonds · protein-protein
  • A–D · 866 Ų buried · 13 hydrogen bonds · protein-protein
  • B–D · 714 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 671 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 3S86 · Crystal Structure of TM0159 with bound IMP · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9WY06 · AlphaFold monomer V2.0 prediction for DITP/XTP pyrophosphatase (Q9WY06) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.